Skip to main content

Advertisement

Log in

Infusion, core decompression, or infusion following core decompression in the treatment of bone edema syndrome and early avascular osteonecrosis of the femoral head

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

An increase in interstitial fluid is an expression of bone marrow edema (BME) and osteonecrosis (ON). The exact pathogenetic processes still remain unknown. Treatment options are mainly symptomatic with core decompression as surgical golden standard with immediate pain relief. Recently, it has been shown that intravenous iloprost can be used to achieve a reduction in BME and ON with a considerable improvement in the accompanying symptoms. The effect of intraveneously applied iloprost alone (12 patients) was studied against core decompression alone (12 patients) as well as iloprost following core decompression (12 patients). We could find a significant improvement in HHS, WOMAC score, SF-36 score and VAS 3 months and 1 year after therapeutical intervention in all treatment groups; however, statistically best results were obtained by combination. Concerning the MRI scans, we found a distinct reduction in BME in all groups again favoring the combination. Concerning ON, the results were not as promising as for BME. Intravenous prostacyclin and core decompression as monotherapy are of efficient therapeutical benefit in the treatment of BME, and the combination of both methods, however, seems to be most promising, also in the treatment of ON. Long-term results and higher number of patients are needed for final statements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Breitenseher MJ, Kramer J, Mayerhoefer ME, Aigner N, Hofmann S (2006) Differential diagnosis of bone marrow edema of the knee joint. Radiologe 46:46–54

    Article  CAS  Google Scholar 

  2. Hofmann S (2005) The painful bone marrow edema syndrome of the hip joint. Wien Klin Wochenschr 117:111–120

    Article  Google Scholar 

  3. Karantanas AH, Drakonaki E, Karachalios T, Korompilias AV, Malizos K (2008) Acute non-traumatic marrow edema syndrome in the knee: MRI findings at presentation, correlation with spinal DEXA and outcome. Eur J Radiol 67:22–33

    Article  Google Scholar 

  4. Korompilias AV, Karantanas AH, Lykissas MG, Beris AE (2009) Bone marrow edema syndrome. Skeletal Radiol 38:425–436

    Article  Google Scholar 

  5. Aigner N, Petje G, Schneider W, Meizer R, Wlk M, Kotsaris S, Knahr K, Landsiedl F (2005) Bone marrow edema syndrome of the femoral head: treatment with the prostacyclin analogue iloprost versus core decompression: an MRI-controlled study. Wien Klin Wochenschr 117:130–135

    Article  Google Scholar 

  6. Hofmann S, Schneider W, Breitenseher M, Urban M, Plenk H Jr (2000) “Transient osteoporosis” as a special reversible form of femur head necrosis. Orthopade 29:411–419

    CAS  PubMed  Google Scholar 

  7. Disch AC, Matziolis G, Perka C (2005) The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost. J Bone Joint Surg Br 87:560–564

    Article  CAS  Google Scholar 

  8. Koo KH, Ahn IO, Kim R, Song HR, Jeong ST, Na JB, Kim YS, Cho SH (1999) Bone marrow edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial MR images. Radiology 213:715–722

    Article  CAS  Google Scholar 

  9. Plenk H Jr, Hofmann S, Eschberger J, Gstettner M, Kramer J, Schneider W, Engel A (1997) Histomorphology and bone morphometry of the bone marrow edema syndrome of the hip. Clin Orthop Relat Res 334:73–84

    Article  Google Scholar 

  10. Berger CE, Kroner AH, Minai-Pour MB, Ogris E, Engel A (2003) Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip. Bone 33:346–351

    Article  CAS  Google Scholar 

  11. Meizer R, Radda C, Stolz G, Kotsaris S, Petje G, Krasny C, Wlk M, Mayerhofer M, Landsiedl F, Aigner N (2005) MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost. Wien Klin Wochenschr 117:278–286

    Article  Google Scholar 

  12. Calder JD, Buttery L, Revell PA, Pearse M, Polak JM (2004) Apoptosis–a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br 86:1209–1213

    Article  CAS  Google Scholar 

  13. Calder JD, Pearse MF, Revell PA (2001) The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. J Bone Joint Surg Br 83:419–422

    Article  CAS  Google Scholar 

  14. Hofmann S, Kramer J, Plenk H (2005) Osteonecrosis of the hip in adults. Orthopade 34:171–183

    Article  CAS  Google Scholar 

  15. Froberg PK, Braunstein EM, Buckwalter KA (1996) Osteonecrosis, transient osteoporosis, and transient bone marrow edema: current concepts. Radiol Clin N Am 34:273–291, x

    CAS  PubMed  Google Scholar 

  16. Balakrishnan A, Schemitsch EH, Pearce D, McKee MD (2003) Distinguishing transient osteoporosis of the hip from avascular necrosis. Can J Surg 46:187–192

    PubMed  PubMed Central  Google Scholar 

  17. Guerra JJ, Steinberg ME (1995) Distinguishing transient osteoporosis from avascular necrosis of the hip. J Bone Joint Surg Am 77:616–624

    Article  CAS  Google Scholar 

  18. Aigner N, Schneider W, Eberl V, Knahr K (2002) Core decompression in early stages of femoral head osteonecrosis: an MRI-controlled study. Int Orthop 26:31–35

    Article  CAS  Google Scholar 

  19. Mont MA, Marulanda GA, Seyler TM, Plate JF, Delanois RE (2007) Core decompression and nonvascularized bone grafting for the treatment of early stage osteonecrosis of the femoral head. InstrCourse Lect 56:213–220

    Google Scholar 

  20. Apel DM, Vince KG, Kingston S (1994) Transient osteoporosis of the hip: a role for core decompression? Orthopedics 17:629–632

    CAS  PubMed  Google Scholar 

  21. Hofmann S, Engel A, Neuhold A, Leder K, Kramer J, Plenk H Jr (1993) Bone-marrow oedema syndrome and transient osteoporosis of the hip. An MRI-controlled study of treatment by core decompression. J Bone Joint Surg Br 75:210–216

    Article  CAS  Google Scholar 

  22. Mihalko WM, Balos L, Santilli M, Mindell ER (2003) Osteonecrosis after powered core decompression. Clin Orthop Relat Res 412:77–83

    Article  Google Scholar 

  23. Grant SM, Goa KL (1992) Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 43:889–924

    Article  CAS  Google Scholar 

  24. Mont MA, Ragland PS, Parvizi J (2006) Surgical treatment of osteonecrosis of the hip. Instr Course Lect 55:167–172

    PubMed  Google Scholar 

  25. Petje G, Radler C, Aigner N, Manner H, Kriegs-Au G, Grill F (2004) Pharmacological management of aseptic osteonecrosis in children. Expert Opin Pharmacother 5:1455–1462

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johannes Beckmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beckmann, J., Schmidt, T., Schaumburger, J. et al. Infusion, core decompression, or infusion following core decompression in the treatment of bone edema syndrome and early avascular osteonecrosis of the femoral head. Rheumatol Int 33, 1561–1565 (2013). https://doi.org/10.1007/s00296-012-2597-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2597-8

Keywords

Navigation